BioSpace News Archive

Aditx Therapeutics, Inc. (Aditxt) (the “Company”) (Nasdaq: ADTX), a life sciences company developing technologies specifically focused on improving the health of the immune system through immune reprogramming and monitoring, today announced the closing of its previously announced $11.0 million initial public offering of 1,226,668 units, each unit consisting of one share of common stock

Today, the U.S. Food and Drug Administration approved Rukobia (fostemsavir), a new type of antiretroviral medication for adults living with HIV who have tried multiple HIV medications and whose HIV infection cannot be successfully treated with other therapies because of resistance, intolerance or safety considerations. “This a

TerrAscend Corp. (CSE:TER) (OTCQX: TRSSF) (“TerrAscend” or the “Company”) today announced that its 2020 annual general meeting of shareholders (the “AGM”) will be held on August 18, 2020 . As a result of the ongoing impact of the COVID-19 pandemic and in accordance with continued public health measures, t

Sensient Technologies Corporation (NYSE: SXT) will hold its conference call to discuss 2020 second quarter results at 8:30 a.m. CDT on Friday, July 17, 2020. To participate in the conference call, contact Chorus Call Inc. at (844) 492-3726 or (412) 317-1078, and ask to join the Sensient Technologies Corporation conference call. Alternatively, the call can be accessed by using the webcast link that will be available on the Inves

Includes $10,000 Cash Prize + P & G Ventures Partnership Opportunity [02-July-2020] COLUMBIA , Mo. and KANSAS CITY, Mo. , July 2, 2020 /PRNewswire/ -- Healium , the makers of a virtual stress relief product that’s powered by consumer wearables recently won the P & G Ventures Innovation Challenge which includes a $10,000 cash prize, the opportunity to par

In a phase III study, a majority (60%) of heavily treatment-experienced adults randomized to receive Rukobia with an optimized background therapy achieved and maintained viral suppression through 96 weeks, addressing a critical unmet need LONDON--( BUSINESS WIRE )-- ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer Inc. and Shionogi Limited as shareholders, today announced that the US Food and Drug Administration

Castle Biosciences, Inc. (Nasdaq: CSTL), announced today that the underwriters of its recently closed underwritten public offering of 2,000,000 shares of its common stock have exercised in full their option to purchase an additional 300,000 shares of common stock at the public offering price of $37.00 per share, less underwriting discounts and commissions. The gross proceeds to Castle Biosciences from the offering, inc

Cipher Pharmaceuticals Inc. (TSX: CPH) (" Cipher " or " the Company ") is pleased to announce that it has appointed seasoned Financial Executive Scott Langille as its new Chief Financial Officer (CFO), he will succeed Interim CFO Nadine Jutlah . Mr. Langille brings with him an extensive background in corporate and oper

Today, the U.S. Food and Drug Administration further assisted health care providers around the country prepare for the upcoming flu season during the COVID-19 pandemic by issuing an emergency use authorization (EUA) for the third diagnostic test for detection and differentiation of the viruses that cause flu and COVID-19 i

Aurora Spine Corporation announced the promotion of Chad Clouse to the position of Chief Financial Officer, effective July 2, 2020.